Errors in Abstract, Results, Table 1, Table 2, Table 3, Discussion, and Visual Abstract - Takeaways - MDSpire

Errors in Abstract, Results, Table 1, Table 2, Table 3, Discussion, and Visual Abstract

Share

1

Errors were identified in the Abstract, Results, Tables 1-3, Discussion, and Visual Abstract of a clinical trial published on March 9, 2026.
2

Table 1 required corrections in the labeling of units for various measurements, including Apgar score and blood parameters.
3

Table 2's primary and secondary outcome estimates for bronchopulmonary dysplasia and other conditions were corrected with specific values.
4

Table 3's relative risk values for bronchopulmonary dysplasia outcomes were also corrected for various analyses.
5

The primary outcome in the Abstract and Discussion was clarified to indicate a 24.0% reduced risk of bronchopulmonary dysplasia in the HFOV group.